CLRB: Cellectar Biosciences Inc. Stocks News on June 28, 2025

CLRB

MT Newswires

2 days ago

Cellectar Biosciences Signs Isotope Supply Agreement With Nusano

Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

CLRB

GlobeNewswire

2 days ago

Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)

CLRB

GlobeNewswire

4 days ago

Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)

Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split

CLRB

GlobeNewswire

10 days ago

Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split

$Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma$

CLRB

GlobeNewswire

17 days ago

Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma

CLRB

MT Newswires

23 days ago

Cellectar Biosciences Expects to Raise $2.5 Million via Stock Sale, Warrant Exercise

Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?

CLRB

Zacks

23 days ago

Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?

Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules

CLRB

GlobeNewswire

23 days ago

Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules

What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

CLRB

Benzinga

24 days ago

What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

CLRB

MT Newswires

24 days ago

Cellectar Biosciences Says FDA Granted Breakthrough Therapy Designation for Experimental Cancer Drug; Shares Rise Pre-Bell

Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)

CLRB

GlobeNewswire

24 days ago

Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)

CLRB

Zacks

a month ago

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

4 Medical Product Stocks to Watch From a Challenging Industry

CLRB

Zacks

a month ago

4 Medical Product Stocks to Watch From a Challenging Industry

CLRB

Thomson Reuters StreetEvents

a month ago

Q1 2025 Cellectar Biosciences Inc Earnings Call

CLRB

GuruFocus.com

a month ago

Cellectar Biosciences Inc (CLRB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...

Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update

CLRB

GlobeNewswire

a month ago

Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025

CLRB

GlobeNewswire

2 months ago

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025

Cellectar Announces Plan to Explore Strategic Alternatives

CLRB

GlobeNewswire

2 months ago

Cellectar Announces Plan to Explore Strategic Alternatives

4 Medical Product Stocks to Buy From a Challenging Industry

CLRB

Zacks

2 months ago

4 Medical Product Stocks to Buy From a Challenging Industry

CLRB

Zacks

3 months ago

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

CLRB

GuruFocus.com

4 months ago

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ...

CLRB

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Cellectar Biosciences Inc Earnings Call

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update

CLRB

GlobeNewswire

4 months ago

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update

Cellectar Biosciences to Present at the 37th Annual Roth Conference

CLRB

GlobeNewswire

4 months ago

Cellectar Biosciences to Present at the 37th Annual Roth Conference

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025

CLRB

GlobeNewswire

4 months ago

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025

Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CLRB

GlobeNewswire

5 months ago

Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

CLRB

GlobeNewswire

5 months ago

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options

CLRB

Benzinga

7 months ago

Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options

Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring

CLRB

GlobeNewswire

7 months ago

Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring

CLRB

MT Newswires

7 months ago

Oppenheimer Adjusts Cellectar Biosciences Price Target to $12 From $14, Maintains Outperform Rating

CLRB

Thomson Reuters StreetEvents

7 months ago

Q3 2024 Cellectar Biosciences Inc Earnings Call

Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update

CLRB

GlobeNewswire

7 months ago

Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225

CLRB

GlobeNewswire

7 months ago

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer

CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024

CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024

Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024

CLRB

GlobeNewswire

8 months ago

Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024

Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q

CLRB

GlobeNewswire

8 months ago

Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131

CLRB

Zacks

10 months ago

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia

CLRB

GlobeNewswire

10 months ago

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia

Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq

CLRB

GlobeNewswire

10 months ago

Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update

CLRB

GlobeNewswire

10 months ago

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

CLRB

GlobeNewswire

a year ago

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

CLRB

MT Newswires

a year ago

Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate

CLRB

MT Newswires

a year ago

Top Premarket Decliners

Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months

Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million

Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

CLRB

GuruFocus.com

a year ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

CLRB

Energy Global

a year ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

CLRB

USA TODAY

a year ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

CLRB

Business Wire

a year ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

CLRB

Business Wire

a year ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips

CLRB

GlobeNewswire

a year ago

SEALSQ to Launch Two New Quantum Resistant Chips

CLRB

Reuters

a year ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

CLRB

GlobeNewswire

a year ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides

CLRB

Simply Wall St.

a year ago

Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Deliver On Growth Plans?

CLRB

Thomson Reuters StreetEvents

a year ago

Q1 2024 Cellectar Biosciences Inc Earnings Call

CLRB

GuruFocus.com

a year ago

Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update

Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024

CLRB

Simply Wall St.

a year ago

Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?

CLRB

Insider Monkey

a year ago

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

CLRB

Thomson Reuters StreetEvents

a year ago

Q4 2023 Cellectar Biosciences Inc Earnings Call

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024

Cellectar Biosciences to Present at the 36th Annual Roth Conference

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Present at the 36th Annual Roth Conference

Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer

Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study

CLRB

Associated Press Finance

a year ago

Chemung Financial: Q4 Earnings Snapshot

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

CLRB

GuruFocus.com

a year ago

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables

CLRB

GlobeNewswire

a year ago

ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

Bakkt Crypto Capabilities Activated Across Multiple International Regions

CLRB

Business Wire

a year ago

Bakkt Crypto Capabilities Activated Across Multiple International Regions

$Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient$

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient

CLRB

Motley Fool

a year ago

Why Calavo Growers Stock Dropped Today

Wrap Technologies, Inc. Appoints Scot Cohen as Chief Executive Officer

CLRB

GlobeNewswire

a year ago

Wrap Technologies, Inc. Appoints Scot Cohen as Chief Executive Officer

Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

CLRB

Reuters

a year ago

Cellectar's blood cancer therapy succeeds in trial

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia

CLRB

GlobeNewswire

a year ago

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia

Billionaire Louis Bacon’s 15 Long-Term Stock Picks

CLRB

Insider Monkey

a year ago

Billionaire Louis Bacon’s 15 Long-Term Stock Picks

Emeren Group Purchases an 86 MWp Solar Portfolio in Spain

CLRB

PR Newswire

a year ago

Emeren Group Purchases an 86 MWp Solar Portfolio in Spain

Pathfinder Bancorp, Inc. Declares Dividend

CLRB

GlobeNewswire

2 years ago

Pathfinder Bancorp, Inc. Declares Dividend

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation

CLRB

Business Wire

2 years ago

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation

Tayon Named Chief Product Officer at American Outdoor Brands

CLRB

PR Newswire

2 years ago

Tayon Named Chief Product Officer at American Outdoor Brands

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

CLRB

Business Wire

2 years ago

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

CLRB

Zacks Small Cap Research

2 years ago

MSCLF: AAK1 Disclosed as Drug Target for DMD Program…

12 Best Healthcare Stocks For the Long-Term

CLRB

Insider Monkey

2 years ago

12 Best Healthcare Stocks For the Long-Term

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

CLRB

GlobeNewswire

2 years ago

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

CLRB

GlobeNewswire

2 years ago

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

CLRB

Insider Monkey

2 years ago

12 Best Recycling Stocks To Buy Now

3 Medical Services Stocks to Buy as Industry Trends Improve

CLRB

Zacks

2 years ago

3 Medical Services Stocks to Buy as Industry Trends Improve

Platinum Group Metals Ltd. Reports 2023 Annual Results

CLRB

Newsfile

2 years ago

Platinum Group Metals Ltd. Reports 2023 Annual Results

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust

CLRB

Business Wire

2 years ago

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript

CLRB

Insider Monkey

2 years ago

Latest Cellectar Biosciences Inc. (CLRB) News on June 28, 2025

Share on Social Networks: